E3V-91434-91360 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-10-18
Dose 1 — Pfizer-BioNTech
2021-11-08
Dose 2 — Pfizer-BioNTech
2021-11-24
Registered in v-safe
2021-11-24
Health check-in — day 14, dose 2
Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cough since first dose Chest pain post second dose

Adult check-in · check-in free text available
2021-12-01
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-12-22
Survey response — day 42, dose 2
MedDRA: Nasal congestion, Pain, Pyrexia — Feeling: Poor · Be unable to work or attend school

Free text: Body aches, fever, stuffy nose

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-10-18	Pfizer-BioNTech	No
2	2021-11-08	Pfizer-BioNTech	No

Free text

Release 10 — day 42, dose 2

2021-12-22

Symptoms: Body aches, fever, stuffy nose

Release 12 — day 14, dose 2

2021-11-24

Symptoms: Cough since first dose Chest pain post second dose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasal congestion	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release